Diagnosis and management of sodium disorders: Hyponatremia and hypernatremia

American Family Physician

Volumn 91, Issue 5, 2015, Pages 299-307

  Braun, Michael M ^a   Barstow, Craig H ^b   Pyzocha, Natasha J ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

^b WOMACK ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CONIVAPTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFUSION FLUID; INSULIN; SODIUM; SODIUM CHLORIDE; STEROID; TOLVAPTAN; ISOTONIC SOLUTION;

ARTICLE; BODY WATER; CLINICAL FEATURE; DIABETES INSIPIDUS; DIAGNOSTIC APPROACH ROUTE; DIURESIS; FLUID INTAKE; FLUID THERAPY; HUMAN; HYPERNATREMIA; HYPERVOLEMIA; HYPONATREMIA; HYPOVOLEMIA; NUTRITIONAL COUNSELING; PLASMA OSMOLALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SODIUM INTAKE; STEROID THERAPY; URINE VOLUME; BLOOD; DIFFERENTIAL DIAGNOSIS; DRUG EFFECTS; PHYSIOLOGY;

DIAGNOSIS, DIFFERENTIAL; DIURESIS; FLUID THERAPY; HUMANS; HYPERNATREMIA; HYPONATREMIA; ISOTONIC SOLUTIONS; SALINE SOLUTION, HYPERTONIC; SODIUM;

EID: 84936770397     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Hoorn EJ, et al. Hyponatremia and mortality: moving beyond associations. Am J Kidney Dis. 2013;62(1):139-149.
2. Mannesse CK, et al. Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: a systematic review. Ageing Res Rev. 2013;12(1):165-173.
3. Gankam-Kengne F, et al. Mild hyponatremia is associated with an increased risk of death in an ambulatory setting. Kidney Int. 2013;83(4): 700-706.
4. Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta. 2003;337(1-2):169-172.
5. Crestanello JA, et al. Preoperative hyponatremia predicts outcomes after cardiac surgery. J Surg Res. 2013;181(1):60-66.
6. Crestanello JA, et al. Does preoperative hyponatremia potentiate the effects of left ventricular dysfunction on mortality after cardiac surgery? J Thorac Cardiovasc Surg. 2013;145(6):1589-1594, 1594e1-1594e2.
7. Vaishya R, et al. Mortality predictions in severe hyponatraemia in emergency inpatients. J Indian Med Assoc. 2012;110(2):94-97.
8. Shchekochikhin DY, et al. Outcome differences in community- versus hospital-acquired hyponatremia in patients with a diagnosis of heart failure. Circ Heart Fail. 2013;6(3):379-386.
9. Hagino T, et al. Hyponatremia at admission is associated with in-hospital death in patients with hip fracture. Arch Orthop Trauma Surg. 2013; 133(4):507-511.
10. Korkmaz I, et al. Baseline characteristics and the association between hyponatraemia and pulmonary embolism prognosis. J Pak Med Assoc. 2013;63(3):331-335.
11. Assadi F. Hyponatremia: a problem-solving approach to clinical cases. J Nephrol. 2012;25(4):473-480.
12. Pfennig CL, et al. Sodium disorders in the emergency department: a review of hyponatremia and hypernatremia. Emerg Med Pract. 2012; 14(10):1-26.
13. Verbalis JG, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 suppl 1):S1-S42.
14. Spasovski G, et al.; Hyponatraemia Guideline Development Group. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170(3):G1-G47.
15. Masri G, et al. Evaluation of hyponatremia. https://online.epocrates.com/noFrame/showPage?method=diseases&MonographId=57 [subscription required]. Accessed October 8, 2014.
16. Sarikonda KV, et al. Hyponatremia. http://www.essentialevidenceplus.com/content/eee/146 [subscription required]. Accessed October 8, 2014.
17. Imbriano LJ, et al. Normal fractional urate excretion identifies hyponatremic patients with reset osmostat. J Nephrol. 2012;25(5):833-838.
18. Carvounis CP, et al. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 2002; 62(6):2223-2229.
19. Albert NM, et al. A randomized controlled pilot study of outcomes of strict allowance of fluid therapy in hyponatremic heart failure (SALT-HF). J Card Fail. 2013;19(1):1-9.
20. Sterns RH, et al. The treatment of hyponatremia. Semin Nephrol. 2009;29(3):282-299.
21. Sood L, et al. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia. Am J Kidney Dis. 2013;61(4):571-578.
22. Hew-Butler T, et al. Consensus statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005. Clin J Sport Med. 2005;15(4):208-213.
23. Moritz ML, et al. 100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy. Metab Brain Dis. 2010;25(1):91-96.
24. Cárdenas A, et al. Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis. J Hepatol. 2012;56(3):571-578.
25. Hauptman PJ, et al.; EVEREST Investigators. Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan. J Card Fail. 2013;19(6):390-397.
26. Schrier RW, et al.; SALT Investigators. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006; 355(20):2099-2112.
27. Josiassen RC, et al. Vaptans: a potential new approach for treating chronic hyponatremia in psychotic patients. Clin Schizophr Relat Psychoses. 2012;6(1):21-26.
28. Berl T, SALTWATER Investigators. Oral tolvaptan is safe and effective in chronic hyponatremia [published correction appears in J Am Soc Nephrol. 2010;21(8):1407]. J Am Soc Nephrol. 2010;21(4):705-712.
29. Dahl E, et al. Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia. Aliment Pharmacol Ther. 2012;36(7):619-626.
30. Lehrich RW, et al. Role of vaptans in the management of hyponatremia. Am J Kidney Dis. 2013;62(2):364-376.
31. McCausland FR, et al. Association of serum sodium with morbidity and mortality in hospitalized patients undergoing major orthopedic surgery. J Hosp Med. 2014;9(5):297-302.
32. Leung AA, et al. Preoperative hypernatremia predicts increased perioperative morbidity and mortality. Am J Med. 2013;126(10):877-886.
33. Adrogué HJ, et al. Hypernatremia. N Engl J Med. 2000;342(20):1493-1499.
34. Funder JW, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(9):3266-3281.
35. Sands JM, et al.; American College of Physicians; American Physiological Society. Nephrogenic diabetes insipidus. Ann Intern Med. 2006; 144(3):186-194.
36. Reynolds RM, et al. Disorders of sodium balance. BMJ. 2006;332 (7543):702-705.
37. Kahn A, et al. Controlled fall in natremia and risk of seizures in hypertonic dehydration. Intensive Care Med. 1979;5(1):27-31.